mended as an important new staging modality. It is cedure has been described previously. [12] [13] [14] Tumors were restaged after laparoscopy and biopsy proven nearly as sensitive as an explorative laparotomy in detecting small peritoneal deposits and when diagnostic metastases or tumor ingrowth lead to exclusion from further surgical exploration. When ingrowth or vasculaparoscopy is combined with ultrasonography, small liver metastases and local ingrowth can be diaglar involvement was suspected without pathology, tumors were scored as doubtful resectable. All other tunosed. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] During diagnostic laparoscopy biopsies can be taken under direct laparoscopic or ultrasound mors were scored as resectable. All patients with doubtful resectable or resectable tumors underwent guidance. The procedure-related morbidity and mortality are relatively low. 14 laparotomy, normally between 1 -4 weeks after diagnostic laparoscopy. It has been shown that laparoscopic staging prevents explorative laparotomies in 5 -64% of patients depending on the type of tumor. [12] [13] [14] [15] [16] [17] [18] [19] However, only
Palliative Treatment
Patients with an irresectable tumor after laparoscopy the early advantages of laparoscopic staging have been evaluated in most studies. The necessity to undergo were offered treatment when indicated. For patients with esophageal tumors and tumors of the gastric later surgical palliative procedures has not yet been studied. In the current study, the long term efficacy of cardia, a tygon tube or Wallstent expandable stent (Schneider [Europe] AG; Bü lack, Switzerland) or Song diagnostic laparoscopy and laparoscopic ultrasonography, defined as early minus later laparotomies, was esophageal endoprosthesis (Sooho Medi-Tech Co., Ltd., Seoul, Korea) was placed and obstructive jaunevaluated.
dice was treated with a biliary polyethylene (PE) endo-
PATIENTS AND METHODS
prosthesis or Wallstent. All patients were discussed The records of 233 consecutive patients who underin an multidiscipline oncology meeting and palliative went diagnostic laparoscopy and laparoscopic ultrasochemotherapy and/or radiotherapy was proposed nography between January 1992 and July 1995 for the within ongoing study protocols. This aspect of palliastaging of upper gastrointestinal malignancies were tive treatment is beyond the scope of this study and reviewed. Only patients in good general condition who will not be discussed. could tolerate a major surgical procedure were included in this staging protocol. Informed consent was Follow-Up obtained before diagnostic laparoscopy was perPatients excluded from explorative laparotomy after formed.
diagnostic laparoscopy were evaluated in January Preoperative diagnostic and staging procedures 1996. Most patients visited the outpatient clinic. When were for esophageal tumors ultrasonography cominformation was not available the patient's general bined with Doppler ultrasonography of the neck and practitioner or referring specialist was contacted. Surabdomen, endoscopic ultrasonography, indirect larvival time was measured as months alive after laparosyngoscopy and, when indicated, bronchoscopy as well.
copy.
For hepatopancreatobiliary tumors a transabdominal
The number and indication for late laparotomies, ultrasound combined with Doppler ultrasound was necessary for palliative treatment during follow-up of performed in all cases; patients with obstructive jaunthe patients, was assessed. dice underwent an endoscopic retrograde cholangioThe overall efficacy of laparoscopic staging was pancreatography with insertion of an endoprosthesis, defined as the number of initially prevented laparotoand CT scans were frequently made in referring hospimies minus the number of late laparotomies. tals. All patients with liver tumors were staged with CT scans. Fine-needle biopsies of possible metastases
RESULTS
were taken under ultrasound or CT guidance. Visceral
Between January 1992 and July 1995, 233 patients with angiography was performed in a minority of patients an upper gastrointestinal tumor underwent laparoto verify vascular involvement if this was suspected scopic staging after conventional staging had not after Doppler ultrasound investigation. Pathology shown any signs of irresectability. Seven patients (3%) proven metastases or total vascular occlusion caused were excluded for various reasons ( of pathology proven metastases. Late laparotomies of cirrhosis (2 patients) or proven metastatic disease indicating dissemination in both sides of the liver (5 were performed between 1 and 13 months after diagnostic laparoscopy in 7 of 47 patients (15%). Six of patients) and/or extrahepatic tumor spread (4 patients) ( Table 2) . Palliative chemotherapy or radiotherthe seven patients had duodenal obstruction and one patient had small bowel obstruction secondary to periapy was given to six patients. Eight of the 10 patients died 4 to 24 months after laparoscopy; 2 patients were toneal carcinomatosis. The overall efficacy of laparoscopic staging in the long term prevention of unnecesstill alive 29 and 39 months, respectively, after laparoscopy. None of the patients required a late laparotomy sary laparotomies was 40 of 226 patients (18%). and the overall efficacy of diagnostic laparoscopy was 43% (10 of 23 patients).
Carcinoma of the Esophagus and Gastric Cardia
In 4 of 64 patients (6%) explorative laparotomy was prevented after laparoscopic staging because of meCarcinoma of the Proximal Bile Duct tastases detected during laparoscopy (Table 2) . One Explorative laparotomy was not performed in 9 of 21 patient underwent palliative radiotherapy and another patients (43%) after laparoscopic staging (Table 2 ). patient underwent placement of a Tygon tube after Four patients had an unresectable gallbladder tumor laparoscopy. Two patients did not undergo palliative and five patients had an unresectable proximal bile treatment. The survival times of these 4 patients were duct tumor. Palliative radiotherapy was given to two 3, 4, 6, and 8 months, respectively, and none was alive of the nine patients (22%) with unresectable tumors. at the time of the evaluation. No late laparotomies Two of the 9 patients (22%) required a late laparotomy, were performed. Overall efficacy of laparoscopy was 1 patient 4 months after laparoscopy for bowel ob-6% (4 of 64 patients).
struction caused by peritoneal carcinomatosis and 1 patient 7 months after laparoscopy for duodenal obCarcinoma of the Liver struction. The mean survival of the 9 patients with Explorative laparotomy was not performed after laparoscopic staging in 10 of 23 patients (43%) because unresectable tumors was 6 months (range, 1 -25 / 7b52$$0966 03-07-97 11:12:43 cana W: Cancer months). The overall efficacy of diagnostic laparosfor later laparotomies in patients in whom an initial copy was 33%. (7/21 patients) laparotomy could be prevented was assessed because it has been suggested that results of prevented laparotPeriampullary Carcinoma omies after laparoscopic staging are too optimistic. After laparoscopic staging, explorative laparotomy was Late laparotomies were necessary in 7 of 47 patients avoided in 17 of 111 patients (15%); 16 patients had (15%). These patients almost all developed duodenal metastases and 1 patient had tumor ingrowth (Table  obstruction and underwent a gastroenterostomy. The 2). Palliation was performed with biliary PE endooverall efficacy of laparoscopic staging decreased to prostheses. Five patients later underwent placement 18% (range, 6 -43%). Despite the outcome of this of a Wallstent after a mean of 4.5 PE stent exchanges study, with a reduction in the number of prevented because of stent dysfunction or occlusion. Palliative laparotomies of 3% (7 of 226 patients) during long chemotherapy and/or radiotherapy was given to three term follow-up, diagnostic laparoscopy remains an patients. Follow-up showed a mean survival of 8 important staging instrument for patients with gastromonths (range, 1 -15 months); 2 of the 17 patients intestinal malignancies. were still alive at the time of the evaluation, 6 and 9
However, this study also shows a different benefimonths, respectively, after laparoscopy. Five of the 17 cial effect of laparoscopic staging for various gastroinpatients (29%) underwent a late laparotomy 1 to 13 testinal tumors. For patients with malignant tumors months after laparoscopy, because of duodenal obin the esophagus and gastric cardia, the overall efficacy struction. No procedure-related deaths occurred. A was only 6%. Diagnostic laparoscopy was only benefigastroenterostomy combined with a hepaticojejunoscial in tumors of the distal esophagus and the gastric tomy was performed in these patients. Another two cardia. Therefore, in the study institution, laparoscopy patients had signs of duodenal obstruction but a lapais now only performed in these patients, increasing rotomy was not performed because they were both in the efficacy of laparoscopic staging. 10 an end stage of their disease. The overall efficacy of In patients with liver tumors, the overall efficacy diagnostic laparoscopy was 11% (12 of 111 patients).
of laparoscopic staging was 43%. This is due to the fact that surgical palliation methods are not frequently Carcinoma of the Pancreatic Body or Tail indicated. The additional value of laparoscopic staging In three of seven patients (43%) explorative laparotof liver tumors shown in this study is in accordance omy was prevented by laparoscopic staging because with literature, John et al. were even able to prevent of unresectable metastatic disease (Table 2) . These 3 unnecessary laparotomies in 64% of their patients with patients survival times of 12, 12, and 13 months, reliver tumors. 15 Diagnostic laparoscopy is useful in despectively, after laparoscopy. None of the patients retecting cirrhosis, metastases in the opposite liver side, ceived adjuvant palliative therapy. The overall efficacy and extrahepatic deposits, all contraindications for reof diagnostic laparoscopy was 43% (3 of 7 patients).
section. Although 22% of patients in the current study with proximal bile duct tumors required a laparotomy DISCUSSION during follow-up, overall efficacy of laparoscopic stagNoninvasive staging plays an important role in the ing was high (33%). This can be explained by the fact therapeutic approach of gastrointestinal malignancies.
that laparoscopy and laparoscopic ultrasound can Recently, laparoscopy in combination with laparoevaluate the liver very accurately and tumor ingrowth scopic ultrasonography has been introduced as an adin both liver sides can be identified, making resection ditional procedure. The advantage of laparoscopic impossible. Furthermore, the difficult diagnosis of staging is generally expressed in terms of prevention proximal bile duct obstruction can be simplified by of unnecessary laparotomies.
11-19 A variety of results laparoscopy with direct view of the hepatoduodenal are reported in the literature showing a rate of avoided ligament and differentiation between gallbladder carlaparotomies between 5% and 64%, depending on the cinoma and benign strictures due to impacted stones, type of tumor. In this study, the number of initially or primary sclerosing cholangitis. Nevertheless, even prevented laparotomies was 21% (range, 6 -43%), after resection of tumors that were thought to be mawhich is in accordance with the literature. lignant preoperatively and during surgery, the resecHowever, these studies all described, as mention specimens revealed benign fibrosing or localized tioned, the number of initially prevented laparotosclerosing lesions in 13.4%. 21 mies. None of the studies analyzed the number of lapIn a limited number of patients with tumors of arotomies that had to be performed during followthe pancreatic body and tail, the overall efficacy was up of the patients because of inadequate nonsurgical palliative treatment. In the current study, the need 43%. Secondary symptoms, such as duodenal obstruc-/ 7b52$$0966 03-07-97 11:12:43 cana W: Cancer
